# Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects

> **NCT04341077** · PHASE1 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- Healthy Adult Male and Female Volunteers

## Interventions

- **DRUG:** SHR3162

## Key facts

- **NCT ID:** NCT04341077
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-10
- **Primary completion:** 2020-04-20
- **Final completion:** 2020-10-20
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2020-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04341077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04341077, "Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04341077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*